Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
The FDA has warned healthcare professionals and consumers not to use certain Advair Diskus (fluticasone propionate and salmeterol inhalation powder, from GlaxoSmithKline) inhalers stolen from a distribution warehouse in 2009 which have been found recently in some pharmacies.
The lot numbers, doses and quantities of the stolen Advair Diskus inhalers are:
- Lot 9ZP2255 – NDC 0173-0696-00, Advair Diskus 250/50, 60 Dose, Exp: Sep 2010 (14,400 inhalers)
- Lot 9ZP3325 – NDC 0173-0697-00, Advair Diskus 500/50, 60 Dose, Exp: Sep 2010 (11,200 inhalers)
The safety and effectiveness of the stolen inhalers cannot be assured and they should not be used. Patients who have products with these lot numbers should immediately stop using them, contact GlaxoSmithKline at (888) 825-5249, and follow up with their healthcare provider. Pharmacists who find Advair Diskus inhalers bearing these lot numbers should remove them from shelves and contact the FDA’s Office of Criminal Investigations (OCI) at (800) 551-3989.
Advair Diskus is indicated for the maintenance treatment of asthma in patients not adequately controlled on other asthma-controller medications or whose disease severity warrants initiation of 2 maintenance therapies.
For more information visit www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm219416.htm.
